四物汤调控内质网应激信号通路改善化疗所致卵巢早衰
该研究通过UPLC-Q-TOF/MS鉴定四物汤化学成分,在4-OOHCY损伤的HUVEC模型及环磷酰胺诱导的POI大鼠和小鼠模型中,探讨四物汤对化疗所致卵巢早衰的保护机制。结果显示四物汤可减轻内质网应激、氧化应激和凋亡,保护HUVEC迁移与成管能力,并改善POI动物模型性激素水平、卵泡计数及卵巢血管生成,其机制涉及下调PERK/eIF2α/ATF4/CHOP信号通路。
要点
- 四物汤可减轻化疗诱导的HUVEC内质网应激、氧化应激与凋亡。
- 四物汤通过下调PERK/eIF2α/ATF4/CHOP通路保护血管内皮功能。
- POI动物模型中四物汤改善性激素、卵泡计数与卵巢血管生成。
核心结论
- 四物汤通过调控内质网应激中PERK/eIF2α/ATF4/CHOP信号通路,保护HUVEC血管生成及POI动物模型对抗化疗损伤。
研究设计与样本
- 采用UPLC-Q-TOF/MS鉴定四物汤化学成分,并以4-OOHCY建立HUVEC损伤模型进行细胞实验。
- 动物实验分别用环磷酰胺建立大鼠和小鼠POI模型,评估动情周期、卵巢指数、组织病理和性激素水平。
主要发现
- 四物汤增强HUVEC活力,降低化疗诱导的内质网应激、氧化应激和凋亡水平。
- 四物汤保护HUVEC的迁移和成管能力,机制涉及下调4-OOHCY触发的PERK/eIF2α/ATF4/CHOP通路激活。
- POI动物模型中四物汤恢复低体重、性激素水平、卵泡计数及卵巢血管生成,并改善内质网应激和凋亡。
临床怎么用
- 四物汤「养血活血」内涵可能与调控内质网应激、保护卵巢微血管相关,可为POI的血管保护提供思路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Premature ovarian insufficiency (POI) is a clinically refractory reproductive system disorder. Our previous studies demonstrated that the traditional Chinese herbal formula Si-Wu-Tang (SWT) might ameliorate POI in animal models by improving ovarian angiogenesis, yet the underlying mechanisms remained unclear. PURPOSE: To explore the mechanisms of the traditional Chinese medicine (TCM) formula SWT on human umbilical vein endothelial cells (HUVECs) and animal models of POI. By studying its mechanisms, the research hopes to reveal the connotation of 'nourishing blood and activating blood circulation' in TCM. METHODS: Ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS) was applied to identify the chemical constituents in SWT. In the cell experiment section, a chemotherapy-induced HUVEC injury model was established using 4-hydroperoxy cyclophosphamide (4-OOHCY). Endoplasmic reticulum stress (ERS) and apoptosis levels were detected. Agonists and inhibitors were applied to clarify the regulatory role of SWT on the ERS signaling pathway. In the animal experiment section, rat and mouse models were established using cyclophosphamide (CY), respectively. The modeling and treatment efficacy were assessed by monitoring estrous cycles, ovarian index, histopathological sections, and sex hormone levels. Multiple techniques were employed to detect ERS and apoptosis levels in ovarian tissue and local microvessels. RESULTS: SWT enhanced HUVEC viability, reduced chemotherapy-induced ERS, oxidative stress, and apoptosis levels. It also protected the migration and tube formation abilities of HUVECs. The underlying mechanisms involved SWT downregulating the activation of the PERK/eIF2α/ATF4/CHOP signaling pathway triggered by 4-OOHCY. In POI animal models, SWT restored low body weight, sex hormone levels, follicle count, and ovarian angiogenesis through ameliorating ERS and apoptosis. CONCLUSION: In summary, SWT protected the angiogenesis of HUVEC and POI animal models against chemotherapy-induced injury by regulating the PERK/eIF2α/ATF4/CHOP signaling pathway in ERS.
引用
- Geng Y, Huang Y, Liu Z, et al. Si-Wu-Tang ameliorates chemotherapy-induced premature ovarian insufficiency by regulating a signaling pathway in endoplasmic reticulum stress. Phytomedicine. 2026. PMID: 41564519. doi:10.1016/j.phymed.2026.157823
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。